US2019263825A1
|
|
Water soluble salts of aldose reductase inhibitors for treatment of diabetic complications
|
US2017368079A1
|
|
Anti-inflammatory and antidiabetic agents
|
US2017362237A1
|
|
Water soluble salts of aldose reductase inhibitors for treatment of diabetic complications
|
US2014228319A1
|
|
Water soluble salts of aldose reductase inhibitors for treatment of diabetic complications
|
WO2014124141A1
|
|
Metformin derivatives for treating diabetes
|
US2014323444A1
|
|
Anti-inflammatory and antidiabetic agents
|
US2014024708A1
|
|
Ursolic acid salts for treating diabetes and obesity
|
US2014011814A1
|
|
Diamine and meglumine salt forms of fatty acids
|
US2012289485A1
|
|
Metformin salts of salicylic acid and its congeners
|
US2012178813A1
|
|
Lipid-lowering antidiabetic agent
|